Filing Flows › Health Care › HWH International (ESYN)
HWH International (ESYN) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Jul 30, 2026 · HWH International (ESYN) Q2 2026 earnings results →
Q2 2026 Revenue down 79% year over year to $64K · 330¢ of every $1 of revenue kept as net profit · operating margin 328.1%
HWH International made $64K in Q2 2026 (-79% Y/Y). Operating margin 328.1%, net earnings $212K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Jul 30, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $64K in Q2 2026, down 79% year over year and roughly flat from the previous quarter.
Gross margin was 31.7%, up 17.5 points from Q2 2025. Operating profit was $211K, a 328.1% margin (up 303.6 points year over year). Net earnings were $212K, up 154% year over year ($211K including minority interests, which bore $1K of losses). The effective tax rate was 0.0%.
Operating cash flow was $478K (up 1676% year over year), 227% of net earnings. Non-cash charges added back $2K of depreciation. Working capital and other items added $265K. Capital expenditures of −$0K left free cash flow of $478K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Jul 30, 2026 | $64K | -79% | 328.1% | $212K | $478K |
| Q1 2026 | 10-Q | May 13, 2026 | $64K | -78% | -976.3% | −$627K | −$193K |
| Q4 2025 | 10-K | Mar 26, 2026 | $55K | -81% | n/m | −$1.9M | −$1.0M |
| Q3 2025 | 10-Q | Oct 22, 2025 | $207K | -40% | -142.7% | −$300K | −$200K |
| Q2 2025 | 10-Q | Aug 14, 2025 | $310K | -7% | 24.5% | $83K | $27K |
| Q1 2025 | 10-Q | May 15, 2025 | $295K | +3% | -179.9% | −$574K | −$555K |
| Q4 2024 | 10-K | Mar 31, 2025 | $287K | +38% | -114.7% | −$329K | −$256K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About HWH International
The Company was originally incorporated in Delaware on October 20, 2021 under the name Alset Capital Acquisition Corp. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company consummated the Business Combination on January 9, 2024 and changed its name from “Alset Capital Acquisition Corp.” to “HWH International Inc.” The Company is an early stage and smaller reporting company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
In its own words, from its 10-K, filed Mar 26, 2026.
HWH International against its Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -79% against the peers' median +5%. Operating margin: 328.1% against the peers' median 1.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| ESYN HWH International | Q2 2026 | $64K | -79% | 328.1% |
| MCK McKesson | Q2 FY27 | $111.0B | +8% | 1.4% |
| COR Cencora | Q3 FY26 | $84.8B | +5% | 1.3% |
| CAH Cardinal Health | Q1 FY27 | $67.5B | +6% | 1.1% |
| HLF Herbalife | Q3 2026 | $1.4B | +6% | 10.3% |
| NUS Nu Skin Enterprises | Q3 2026 | $311M | -15% | 1.6% |
| COSM Cosmos Health | Q2 2026 | $19.0M | +29% | -15.4% |
| MEDS DataMeds AI | Q2 2026 | $1.8M | -77% | -412.7% |
| STEK Stemtech | Q2 2026 | $629K | -10% | -20.0% |
Source: HWH International 10-Q on SEC EDGAR · CIK 1897245 · Wholesale-Drugs, Proprietaries & Druggists' Sundries
13F: who owns ESYN and who is buying
More on ESYN
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results